Proto Labs (NYSE:PRLB – Get Free Report) is expected to announce its Q2 2026 results before the market opens on Friday, July 31st. Analysts expect Proto Labs to announce earnings of $0.54 per share and revenue of $144.5330 million for the quarter. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Friday, July 31, 2026 at 8:30 AM ET.
Proto Labs (NYSE:PRLB – Get Free Report) last issued its quarterly earnings data on Friday, May 1st. The industrial products company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The firm had revenue of $139.34 million during the quarter, compared to analysts’ expectations of $135.31 million. During the same period last year, the company earned $0.33 earnings per share. The business’s revenue was up 10.4% on a year-over-year basis. On average, analysts expect Proto Labs to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Proto Labs Stock Performance
Shares of NYSE PRLB opened at $75.13 on Wednesday. The stock has a market cap of $1.79 billion, a price-to-earnings ratio of 70.88 and a beta of 1.38. Proto Labs has a fifty-two week low of $38.62 and a fifty-two week high of $83.15. The firm’s 50-day simple moving average is $76.82 and its 200 day simple moving average is $66.38.
Analysts Set New Price Targets
Read Our Latest Report on PRLB
Insider Transactions at Proto Labs
In other news, Director Sven Wehrwein sold 2,000 shares of the stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total transaction of $154,560.00. Following the transaction, the director directly owned 32,505 shares in the company, valued at approximately $2,511,986.40. This represents a 5.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael R. Kenison sold 16,030 shares of Proto Labs stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total transaction of $1,113,924.70. Following the completion of the transaction, the insider owned 18,683 shares in the company, valued at approximately $1,298,281.67. The trade was a 46.18% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 25,663 shares of company stock worth $1,804,727 in the last 90 days. Company insiders own 1.30% of the company’s stock.
Institutional Investors Weigh In On Proto Labs
Large investors have recently added to or reduced their stakes in the company. Royal Bank of Canada grew its position in shares of Proto Labs by 51.3% in the 1st quarter. Royal Bank of Canada now owns 6,510 shares of the industrial products company’s stock worth $228,000 after buying an additional 2,207 shares during the last quarter. AQR Capital Management LLC boosted its stake in Proto Labs by 3.3% during the first quarter. AQR Capital Management LLC now owns 63,871 shares of the industrial products company’s stock worth $2,238,000 after acquiring an additional 2,040 shares in the last quarter. NewEdge Advisors LLC boosted its position in shares of Proto Labs by 7,380.0% in the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after purchasing an additional 738 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Proto Labs by 68.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 21,756 shares of the industrial products company’s stock worth $871,000 after buying an additional 8,864 shares during the last quarter. Finally, Hsbc Holdings PLC bought a new position in Proto Labs during the 2nd quarter valued at approximately $480,000. Institutional investors own 84.54% of the company’s stock.
About Proto Labs
Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.
Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.
Featured Stories
- Five stocks we like better than Proto Labs
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
